The Therapeutic Goods Administration (TGA) approved a shelf-life of 6 months from the date of manufacture of NUVAXOVID (Novavax), provided that approved storage conditions between 2°C to 8°C have been maintained.
Cartons and vials of Nuvaxoid were labelled with an expiry in the month/year format but continue to meet the TGA approved shelf life up to 6 months after the date of manufacture. This is reflected in the revised expiry date when expressed as a day/month/year.
The changed expiry date applies to the following batch number that has been distributed:
Batch Number |
Labelled Expiry Date |
Date of Manufacture |
Revised Expiry Date |
4301MF004 |
April 22 |
22 November 2021 |
22 May 2022 |
This revised expiry date applies to all stock on site provided that approved storage conditions have been maintained. Please update the expiry date on any vials you have on site to reflect the revised expiry date.
Deliveries of these batches will continue for the next few weeks while a new batch of Novavax undergoes assessment and release to the Commonwealth.
Note that the packaging associated with the affected batches that are delivered will be labelled with a use by date to reflect the revised expiry dates. Individual vials will not be relabelled with the revised expiry dates. Read more here.
